GENE ONLINE|News &
Opinion
Blog

Deals
M&A Neuroscience
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
M&A Biosimilar
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
Deals BIO CEO & Investor Digital Conference
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
Funding tRNA
tRNA Startup Clinches $24 Million from ARCH, Takeda and 8VC to Fix Protein Mutations
2022-02-25
Funding Targeted Protein Degradation
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Funding Neurodegenerative Disease
Pfizer, Lilly-Backed Neuro Company Bags $64 Million Series B To Correct Progranulin Deficiency in Dementia
2022-02-11
China Cell Therapy
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
Technology Digital Healthcare
Pfizer and Alex Therapeutics Ink Partnership for Providing Digital Therapeutics to Patients, Starting in Germany
2022-02-04
Deals Mental Disorder
MindMed’s MM-120 May Give a New Hope for Generalized Anxiety Disorder
2022-01-30
Asia-Pacific CDMO
Fujifilm Expands CDMO Operations by Buying Atara’s Cell Therapy Plant for $100 Million
2022-01-27
Funding COVID-19
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Deals Microbiome
OpenBiome and the University of Minnesota collaborate to give Microbes to those in Need
2022-01-26
Manufacturing SPAC
Psychedelics Player Goes Public via SPAC
2022-01-25
Asia-Pacific CDMO
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
M&A Epilepsy
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
1 … 22 23 24 25 26 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top